entertainment -WSS

entertainment

author：focus 2025-10-01 02:13:35 - browse：7

Drew Weissman (left) and Katalin Karikó (right) — Drew Weissman (left) and Katalin Karikó, whose longtime partnership was recognized with a Nobel Prize on Monday. Peggy Peterson/Penn Medicine

The most noteworthy aspect of awarding the Nobel Prize in medicine or physiology to two pioneers of mRNA research was not who won Monday — Katalin Karikó and Drew Weissman were widely expected to get the accolade for discoveries that made it possible to deliver the finicky molecule to cells and enabled the record-breaking development of vaccines that tamed the Covid-19 pandemic. It was the way the two scientists worked together.

The Nobel committee framed Karikó and Weissman’s work as a prime example of complementary expertise, with Karikó focused on RNA-based therapies and Weissman bringing a deep knowledge about immune responses to vaccines. In a rare moment for science’s top honor, which elevates the individual contributions of one, two, or at most, three researchers to a particularly impactful breakthrough, it is a celebration of a true scientific partnership — a durable and fruitful collaboration spanning more than two decades of working shoulder-to-shoulder at the lab bench that turned a scientific backwater into a blockbuster technology.

“We couldn’t get funding, we couldn’t get publications, we couldn’t get people to notice mRNA as something interesting,” Weissman told reporters at a press conference Monday at the University of Pennsylvania. “But Kati lit the match and we spent the rest of the next 20 plus years working together figuring out how to get it to work. We would sit together in 1997 and afterwards and talk about all the things we thought RNA could do. And that’s why we never gave up,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： The battle over 'scope creep' and who gets to be called 'doctor'

explore

WSS

What it's like to live with paralysis for one psychologist

Home health providers sue Medicare over payment cuts

Eisai exec who led development of Alzheimer’s drug to retire

Search called off for baby washed away in Pennsylvania flash flood

ACA's risk program benefits Blue Cross Blue Shield insurers

Medicare wants to send $9 billion to 340B hospitals

hotspot

entertainment

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

Will the FTC rein in IQVIA's health data empire?

In age of alternative facts, a scholarly course on calling out crap

CDC Director Mandy Cohen on transparency, trust, and health

The cancer drug shortage isn’t new — and neither are the solutions

Biogen says it will cut costs by $700 million, slash 1,000 jobs

Drug repurposing or repositioning? The language matters

Home health providers sue Medicare over payment cuts

Activists slam private health insurers over coverage restrictions

How doctors’ personal politics affect patients

leisure time

How doctors’ personal politics affect patients

ACA's risk program benefits Blue Cross Blue Shield insurers

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Wisconsin governor employs partial veto to fund schools for 4 centuries

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

Why patients can’t get everything they want on drug pricing

explore

Wikipedia

knowledge

hotspot